[Federal Register Volume 90, Number 39 (Friday, February 28, 2025)]
[Notices]
[Pages 10946-10947]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-03217]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--Biopharmaceutical Manufacturing Preparedness
Consortium
Notice is hereby given that, on January 14, 2025, pursuant to
section 6(a) of the National Cooperative Research and Production Act of
1993, 15 U.S.C. 4301 et seq. (``the Act''), Biopharmaceutical
Manufacturing Preparedness Consortium (``BioMaP-Consortium'') has filed
written notifications simultaneously with the Attorney General and the
Federal Trade Commission disclosing changes in its membership. The
notifications were filed for the purpose of extending the Act's
provisions limiting the recovery of antitrust plaintiffs to actual
damages under specified circumstances.
Specifically, Bella Biologics, Inc., Cohoes, NY; Biotech Resources
Group LLC, Gaithersburg, MD; CellCo, San Francisco, CA; Mercury Bio,
Inc., Santa Fe, NM; Meridian Medical Technologies LLC, Columbia, MD;
National Institute for Pharmaceutical Technology and Education, Inc.,
Minneapolis, MN; Noramco LLC, Wilmington, DE; PATHOLOGY ASSIST-TEMP,
INC., Chantilly, VA; Parkdale Advanced Materials, Inc., Gastonia, NC;
Purisys LLC, Athens, GA; QYK BRANDS LLC, GARDEN GROVE, CA; Telesis Bio,
San Diego, CA; WPT Corp., Beaver Dam, KY; Aldevron LLC, Fargo, ND;
Ampulis, Inc., West Chester, PA; BioBlue CMC/Manufacturing Consulting
LLC, San Diego, CA; BioNet-Asia Co., Ltd., Bangkok, KINGDOM OF
THAILAND; Caplugs, Buffalo, NY; EKF Diagnostics, Inc., Boerne, TX;
Epimeron USA, Inc. dba Willow Biosciences, Sunnyvale, CA; Fitesa
Simpsonville, Inc., Simpsonville, SC; Hills, Inc., West Melbourne, FL;
Hyacinth Proteins, Twin Falls, ID; Premas Biotech Pvt, Ltd., Gurgaon,
REPUBLIC OF INDIA; Pyramid Labs, Costa Mesa, CA; Sarfez
Pharmaceuticals, Inc., Vienna, VA; Technology Engineering Corp.,
Montgomery, AL; Valaria Technical Consultants LLC, Westminster, MD;
Vedanta Biosciences, Inc., Cambridge, MA; Vega Technology Group LLC,
North Canton, OH; Virginia Tech Applied Research Corp., Arlington, VA;
Woodstock Sterile Solutions, Woodstock, IL; American Nitrile Operation
LLC, Grove City, OH; Azzur Cleanrooms-On Demand LLC, Devens, MA;
BlueHalo Labs LLC, Arlington, VA; CENTRIENT PHARMACEUTICALS
INTERNATIONAL B.V., Delft, KINGDOM OF THE NETHERLANDS; Cascade
Biocatalysts, Inc., Denver, CO; Focus Industries Med LLC, Gold Beach,
OR; Genvax Technologies, Inc., Ames, IA; HANS Scientific LLC,
Farmington Hills, MI; JLMillan Consulting LLC, Evans, GA; Klim-Loc
Medical, Inc., Carbondale, CO; Maxim Biomedical, Inc., Rockville, MD;
Q-VANT Biosciences, Inc., Forestdale, MA; Sidra Medical Supply, Inc.,
Elmont, NY; Simon Williams Pharma Consulting (SWPC) LLC, Gibbsboro, NJ;
UNITED STATES ANTIMONY CORPORATION,
[[Page 10947]]
Thompson Falls, MT; Unicorn Biotechnologies, Inc., Newark, NJ; and
Wacker Biotech US, Inc., San Diego, CA, have been added as parties to
this venture.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open, and the BioMaP-Consortium intends to
file additional written notifications disclosing all changes in
membership.
On January 5, 2024, the BioMaP- Consortium filed its original
notification pursuant to section 6(a) of the Act. The Department of
Justice published a notice in the Federal Register pursuant to section
6(b) of the Act on April 16, 2024 (89 FR 26923).
The last notification was filed with the Department on October 3,
2024. A notice was published in the Federal Register pursuant to
section 6(b) of the Act on December 20, 2024 (89 FR 104212).
Suzanne Morris,
Deputy Director Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2025-03217 Filed 2-27-25; 8:45 am]
BILLING CODE P